Register for email alerts and news feeds:
This journal | BMJ Group
rss
Annals of the Rheumatic Diseases 2000;59:20-25; doi:10.1136/ard.59.1.20
Copyright © 2000 BMJ Publishing Group Ltd & European League Against Rheumatism.
Ann Rheum Dis 2000;59:20-25 ( January )

Extended report

Increased serum concentrations of soluble HLA-class I antigens in hepatitis C virus related mixed cryoglobulinaemia Sergio Migliaresia, Alessandro Bresciania b, Lucia Ambrosonea, Marcantonio Speraa b, Deborah Barbarulob, Vincenza Lombarib, Giuseppe Pirozzib, Guglielmo Borgiac, Maria Luisa Lombardib, Giuseppe Tirria, Ciro Manzob

a Istituto di Clinica Medica, Reumatologia, Seconda Università degli Studi, Napoli, Italy, b Servizio di Oncologia Sperimentale C, Immunologia, Istituto Tumori Fondazione Pascale, Napoli, Italy, c Istituto di Malattie Infettive, Università degli Studi "Federico II", Napoli, Italy

Correspondence to: Dr S Migliaresi, Istituto di Clinica Medica, Reumatologia, Seconda Università, Policlinico via Pansini 5, 80131 Napoli, Italy

Accepted for publication 13 August 1999

OBJECTIVE---To investigate whether quantitative alterations of both beta 2microglobulin (beta 2µ) associated HLA class I heavy chains (sHLA-I) and beta 2 µ free class I heavy chains (sHLA-FHC) in sera of patients with hepatitis C virus (HCV) infection occur and whether they distinguish patients with mixed cryoglobulinaemia (MC).
METHODS---83 HCV infected patients were studied and divided into three groups: (A) without cryoglobulinaemia (n=21), (B) with polyclonal MC (n=20), (C) with monoclonal MC (n=42). Serum sHLA-I and sHLA-FHC were measured by double determinant radioimmunoassay using monoclonal antibodies: TP25.99 as catching antibody, and NAMB-1 and HC-10 as revealing antibodies. Western blot identified HLA-I isoforms.
RESULTS---The serum concentrations of sHLA-I and of sHLA-FHC in HCV infected patients versus controls were respectively 1.3(0.5) µg/ml (mean (SD)) versus 0.8 (0.3) (p<0.001) and 13.9 (7.1) ng/ml versus 9.2 (5) (p<0.001). sHLA-I were 1.01 (0.4) µg/ml in group A, 1.04 (0.4) µg/ml in group B, and 1.47 (0.4) µg/ml in group C (p=0.001). Statistical analysis showed a significant difference versus controls for groups B (p<0.02) and C (p<0.001). sHLA-FHC were 12.8 (8.3) ng/ml in group A, 17.2 (7.1) ng/ml in group B, and 12.9 (6.2) ng/ml in group C (p<0.02). A significant difference versus controls for each group was found (p<0.02, p<0.001, and p<0.02, respectively). Different patterns of sHLA-I isoforms were observed.
CONCLUSIONS---Increased serum concentrations of sHLA-I and sHLA-FHC characterise HCV infected patients. The highest sHLA-I concentrations seem to distinguish patients with monoclonal MC. In this last condition sHLA could play a part in the HCV escape and in B cell proliferation. The significance of sHLA-FHC is still undefined.


© 2000 by Annals of the Rheumatic Diseases

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Toussirot, E, Saas, P, Pariset, J, Chabod, J, Tiberghien, P, Wendling, D (2006). Decreased levels of serum soluble HLA class I antigens in HLA-B27 positive spondyloarthropathies. Ann Rheum Dis 65: 279-280 [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs